These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35147657)
1. Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore. Tan SHX; Pung R; Wang LF; Lye DC; Ong B; Cook AR; Tan KB JAMA; 2022 Mar; 327(12):1181-1182. PubMed ID: 35147657 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans. Mayr FB; Talisa VB; Shaikh O; Yende S; Butt AA N Engl J Med; 2022 Apr; 386(14):1375-1377. PubMed ID: 35139265 [No Abstract] [Full Text] [Related]
5. Israel's high case plateau may offer worrisome portent. Wadman M Science; 2021 Sep; 373(6562):1428-1429. PubMed ID: 34554791 [No Abstract] [Full Text] [Related]
6. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study. Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study. Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P; BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968 [TBL] [Abstract][Full Text] [Related]
8. Audio Interview: Covid-19 as an Endemic Disease. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2022 Feb; 386(6):e21. PubMed ID: 35139281 [No Abstract] [Full Text] [Related]
9. Scientists see a 'really, really tough winter' with Omicron. Kupferschmidt K Science; 2021 Dec; 374(6574):1421-1422. PubMed ID: 34914506 [No Abstract] [Full Text] [Related]
10. SARS-CoV-2 vaccine boosters: The time to act is now. Petersen M; Schwab J; Havlir DV PLoS Med; 2021 Dec; 18(12):e1003882. PubMed ID: 34882675 [TBL] [Abstract][Full Text] [Related]
11. Audio Interview: A New Look at Covid-19 Vaccine Boosters. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Oct; 385(17):e72. PubMed ID: 34670050 [No Abstract] [Full Text] [Related]
12. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach? Sarpatwari A; Pandya A; Hyle EP; Persad G Ann Intern Med; 2022 Feb; 175(2):280-282. PubMed ID: 34748375 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 boosters in rich nations will delay vaccines for all. Chagla Z; Pai M Nat Med; 2021 Oct; 27(10):1659-1660. PubMed ID: 34465921 [No Abstract] [Full Text] [Related]
15. Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron. Accorsi EK; Britton A; Shang N; Fleming-Dutra KE; Link-Gelles R; Smith ZR; Derado G; Miller J; Schrag SJ; Verani JR N Engl J Med; 2022 Jun; 386(25):2433-2435. PubMed ID: 35613039 [No Abstract] [Full Text] [Related]
16. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters. Rababa'h AM; Abedalqader NN; Ababneh M Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254 [TBL] [Abstract][Full Text] [Related]